Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer’s patients. Insurers selling coverage in North Carolina, Pennsylvania and New ...

Some veterans will be able to get help affording a new Alzheimer’s treatment. The VA said it will cover Lecanemab, also known as Leqembi, after it was given accelerated approval by the U.S. F… ...

This is the first time that Medicare will not cover an FDA-approved treatment upon approval. Every FDA-approved drug is covered by Medicare, except for Alzheimer’s.

Unless Medicare widely covers these drugs, they will be unaffordable for the vast majority of consumers and the market will dry up. For example, the most recent anti-Alzheimer’s drug to win FDA ...

DEAR SAVVY SENIOR: What exactly does Medicare cover when it comes to Alzheimer's disease? Medicare pays 80% of these costs, and you will be responsible for the remaining 20% after you've ...

Insurers selling coverage in North Carolina, Pennsylvania and New York, among other states, told The Associated Press they won’t cover Leqembi with insurance offered on the individual market and ...

Updated: 1:44 PM CDT Aug 11, 2023 By TOM MURPHY AP Health Writer Insurers won't cover new Alzheimer's treatment for some customers Updated: 1:44 PM CDT Aug 11, 2023 ...

Several health plans in the U.S. will not cover the recently approved Alzheimer’s drug for certain customers, exposing those patients to thousands of dollars in potential costs.

Insurers selling coverage in North Carolina, Pennsylvania and New York, among other states, told The Associated Press they won’t cover Leqembi with insurance offered on the individual market and ...